Farther Finance Advisors, LLC Bridge Bio Pharma, Inc. Transaction History
Farther Finance Advisors, LLC
- $5 Trillion
- Q2 2025
A detailed history of Farther Finance Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 210 shares of BBIO stock, worth $9,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
210
Previous 224
6.25%
Holding current value
$9,655
Previous $7.4 Million
22.61%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
184MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$1.01 Billion2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$886 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$685 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$572 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$330 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.82B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...